WEBULL
WebtradeDownload

Isracard (TASE:ISCD) Returned To Profit, Is The Stock Still Overvalued?

Simply Wall St · 1d ago

Isracard (TASE:ISCD) reported second quarter and half year 2026 results that showed higher revenue and a shift from loss to profit. Investors now have fresh numbers to reassess the stock.

The earnings return to profit has not yet translated into strong share price momentum for Isracard. The stock has a 30 day share price return of 4.84%, while the year to date share price return is down 30.35% and the 1 year total shareholder return is down 17.67%. However, the 5 year total shareholder return remains positive at 28.38%.

See how Isracard compares with other financial stocks seeking to turn improved earnings into a sustained share price recovery in a curated list of 275 high quality undervalued stocks.

Isracard has moved back into profit while the share price is still nursing a steep year to date decline. Is the recent uptick a reset in how the business is valued, or just a brief shift in sentiment before the next move?

Price-to-Earnings of 15.8x: Is it justified?

Isracard trades on a P/E of 15.8x, which looks full when set against its recent share price weakness and the company’s mixed track record on earnings.

The P/E ratio compares the current share price with earnings per share. For a credit card and consumer finance business like Isracard, it reflects what investors are paying today for each shekel of current earnings and what they expect those earnings to do over time. A higher P/E often signals that the market is factoring in either stronger profitability or a relatively lower risk profile.

Here, the P/E of 15.8x sits above both the Asian Consumer Finance industry average of 12x and the peer average of 10.7x. That is a clear premium. This is despite statements that Isracard’s earnings have declined by 21.7% per year over the past 5 years and that it has only recently moved back into profit.

Investors paying this higher multiple should be aware that it is also alongside a low Return on Equity of 6.8%, a high level of debt, and a valuation signal from the SWS DCF model that estimates the future cash flow value at ₪5.31 per share compared with the last close of ₪11.04. While markets can and do assign premiums for various reasons, these reference points suggest the current P/E is rich compared with both peers and the modelled cash flow value.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-Earnings of 15.8x (OVERVALUED)

However, investors still face risks if Isracard’s high debt and relatively low 6.8% Return on Equity persist, or if earnings momentum fails to support the current P/E.

Find out about the key risks to this Isracard narrative.

Another view using the SWS DCF model

The P/E of 15.8x suggests the market is paying up for Isracard today. The SWS DCF model points in a different direction. It estimates a future cash flow value of ₪5.31 per share compared with the recent price of ₪11.04, which indicates the stock screens as overvalued on this method.

This gap between price and modelled value raises a simple question for investors: Is the market correctly pricing in a stronger future for Isracard, or is the SWS DCF model a useful warning sign to treat the current valuation with extra care?

Look into how the SWS DCF model arrives at its fair value.

ISCD Discounted Cash Flow as at Aug 2026
ISCD Discounted Cash Flow as at Aug 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Isracard for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 275 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If the mixed signals on Isracard leave you unsure, act while the data is fresh and review both sides of the story with 1 key reward and 3 important warning signs

Looking for more investment ideas beyond Isracard?

If you found Isracard’s valuation signals useful, do not stop here. Broaden your watchlist now so you are not late to the next opportunity.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.